Previous Article | Next Article 
Molecular and Cellular Biology, September 2004, p. 8264-8275, Vol. 24, No. 18
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.18.8264-8275.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Phosphorylation and Alternative Pre-mRNA Splicing Converge To Regulate Myocyte Enhancer Factor 2C Activity
Bangmin Zhu and Tod Gulick*
Diabetes Research Laboratory, Department of Medicine, Massachusetts General Hospital, Charlestown, and Department of Medicine, Harvard Medical School, Boston, Massachusetts
Received 15 February 2004/
Returned for modification 5 April 2004/
Accepted 11 June 2004
Myocyte enhancer factor 2 (MEF2) transcription factors play pivotal roles in cardiac, muscle, and neuron gene expression. All products of MEF2 genes have a common amino-terminal DNA binding and dimerization domain, but the four vertebrate MEF2 gene transcripts are alternatively spliced among coding exons to produce splicing isoforms. In MEF2C alone, alternative splice acceptors in the last exon give forms that include or exclude a short domain that we designate
. We show that MEF2C is expressed exclusively as
isoforms in heart tissue and predominantly as
in other adult tissues and in differentiating myocytes. MEF2C
isoforms are much more robust than
+ forms in activating MEF2-responsive reporters in transfected fibroblasts despite indistinguishable expression levels, and they better synergize with MyoD in promoting myogenic conversion. One-hybrid transcription assays using Gal4-MEF2C fusions give similar distinctions between
and
+ isoforms in all cell types tested, including myocytes. Cis effects of
on MEF2C DNA binding, dimerization, protein stability, or response to CaM or p38 mitogen-activated protein kinase signaling are not apparent, and the isolated
domain represses transcription when fused to Gal4. One phosphoserine residue is present within the
domain according to tandem mass spectrometry, and mutation of this residue abolishes
-mediated transrepression. A similar activity is present in the constitutive
domain and serine phosphoacceptor of MEF2A. Our findings indicate that
functions autonomously as a phosphoserine-dependent transrepressor to downregulate transactivation function of MEF2 factors and that alternative splicing and serine phosphorylation converge to provide complex combinatorial control of MEF2C activity.
* Corresponding author. Mailing address: Diabetes Research Laboratory, Massachusetts General Hospital, MGH East, CNY 149 8219, Charlestown, MA 02129. Phone: (617) 724-2356. Fax: (617) 726-9452. E-mail:
gulick{at}helix.mgh.harvard.edu.
Molecular and Cellular Biology, September 2004, p. 8264-8275, Vol. 24, No. 18
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.18.8264-8275.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lovato, T. L., Adams, M. M., Baker, P. W., Cripps, R. M.
(2009). A Molecular Mechanism of Temperature Sensitivity for Mutations Affecting the Drosophila Muscle Regulator Myocyte Enhancer Factor-2. Genetics
183: 107-117
[Abstract]
[Full Text]
-
Khiem, D., Cyster, J. G., Schwarz, J. J., Black, B. L.
(2008). A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc. Natl. Acad. Sci. USA
105: 17067-17072
[Abstract]
[Full Text]
-
Maiti, D., Xu, Z., Duh, E. J.
(2008). Vascular Endothelial Growth Factor Induces MEF2C and MEF2-Dependent Activity in Endothelial Cells. IOVS
49: 3640-3648
[Abstract]
[Full Text]
-
Ramachandran, B., Yu, G., Gulick, T.
(2008). Nuclear Respiratory Factor 1 Controls Myocyte Enhancer Factor 2A Transcription to Provide a Mechanism for Coordinate Expression of Respiratory Chain Subunits. J. Biol. Chem.
283: 11935-11946
[Abstract]
[Full Text]
-
Ramachandran, B., Yu, G., Li, S., Zhu, B., Gulick, T.
(2008). Myocyte Enhancer Factor 2A Is Transcriptionally Autoregulated. J. Biol. Chem.
283: 10318-10329
[Abstract]
[Full Text]
-
Gregoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., Yang, X.-J.
(2007). Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2. Mol. Cell. Biol.
27: 1280-1295
[Abstract]
[Full Text]
-
Shalizi, A., Gaudilliere, B., Yuan, Z., Stegmuller, J., Shirogane, T., Ge, Q., Tan, Y., Schulman, B., Harper, J. W., Bonni, A.
(2006). A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.. Science
311: 1012-1017
[Abstract]
[Full Text]
-
Gregoire, S., Tremblay, A. M., Xiao, L., Yang, Q., Ma, K., Nie, J., Mao, Z., Wu, Z., Giguere, V., Yang, X.-J.
(2006). Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation. J. Biol. Chem.
281: 4423-4433
[Abstract]
[Full Text]
-
Zhu, B., Ramachandran, B., Gulick, T.
(2005). Alternative Pre-mRNA Splicing Governs Expression of a Conserved Acidic Transactivation Domain in Myocyte Enhancer Factor 2 Factors of Striated Muscle and Brain. J. Biol. Chem.
280: 28749-28760
[Abstract]
[Full Text]
-
Feriotto, G., Finotti, A., Volpe, P., Treves, S., Ferrari, S., Angelelli, C., Zorzato, F., Gambari, R.
(2005). Myocyte Enhancer Factor 2 Activates Promoter Sequences of the Human A{beta}H-J-J Locus, Encoding Aspartyl-{beta}-Hydroxylase, Junctin, and Junctate. Mol. Cell. Biol.
25: 3261-3275
[Abstract]
[Full Text]
-
Gregoire, S., Yang, X.-J.
(2005). Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors. Mol. Cell. Biol.
25: 2273-2287
[Abstract]
[Full Text]